Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of

M A Grotzer1, A Eggert, T J Zuzak

  • 1Division of Oncology, The Children's Hospital of Philadelphia, Pennsylvania 19104, USA.

Oncogene
|October 13, 2000
PubMed

Insights

Childhood primitive neuroectodermal brain tumors (PNETs) can be targeted with TNF-related apoptosis-inducing ligand (TRAIL). TRAIL-resistance in PNETs is linked to a lack of caspase-8, which can be reversed with methyltransferase inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in various solid tumors but not normal tissues.
  • Childhood primitive neuroectodermal brain tumors (PNETs) are a significant challenge in pediatric oncology.

Purpose of the Study:

  • To investigate the TRAIL death pathway and its therapeutic potential in human PNET cell lines.
  • To identify mechanisms of TRAIL-resistance in PNETs.

Main Methods:

  • Assessed TRAIL-induced apoptosis in 8 human PNET cell lines.
  • Correlated TRAIL sensitivity with mRNA expression of TRAIL, its receptors (TRAIL-R1-R4), cFLIP, caspase-3, and caspase-8.
  • Investigated the effect of 5-aza-2'-deoxycytidine on TRAIL-resistant PNET cells.

Main Results:

  • Three of 8 PNET cell lines were sensitive to TRAIL-induced apoptosis.
  • TRAIL sensitivity did not correlate with TRAIL receptor or cFLIP expression.
  • TRAIL-sensitive PNETs expressed caspase-8 (mRNA and protein), while resistant PNETs lacked caspase-8 protein.
  • 5-aza-2'-deoxycytidine restored caspase-8 expression and TRAIL sensitivity in resistant PNET cells, suggesting epigenetic regulation.

Conclusions:

  • Loss of caspase-8 mRNA expression is a key mechanism of TRAIL-resistance in PNET cells.
  • Recombinant soluble TRAIL, potentially combined with methyltransferase inhibitors, shows promise for PNET therapy.
  • Epigenetic silencing of caspase-8 may be a targetable vulnerability in PNET treatment.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...